Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
CNY 75.33
(-0.49%)
CNY 75.33
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.6 Billion | 4.13 Billion | 1.68 Billion | 468.2 Million | 272.68 Million | 208.3 Million |
| Net Income | 1.24 Billion | 4.86 Billion | 2.07 Billion | 681.81 Million | 210.3 Million | 292.87 Million |
| Depreciation & Amortization | 255.61 Million | 151.9 Million | 105.27 Million | 84.46 Million | 80.5 Million | 71.09 Million |
| Deferred income taxes | -109.1 Million | 20.11 Million | -12.47 Million | 38.31 Million | -29.65 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -169.14 Million | -938.6 Million | -620.34 Million | -352.28 Million | -23.74 Million | -42.15 Million |
| Other non-cash items | 1.05 Billion | 55.99 Million | 117.8 Million | 54.2 Million | 5.61 Million | -113.5 Million |
| Investing Cash Flow | -2.11 Billion | -3.51 Billion | -1.01 Billion | -295.39 Million | -198.36 Million | -352.51 Million |
| Investments in PPE | -1.15 Billion | -929.91 Million | -1.04 Billion | -390.43 Million | -162 Million | -246.06 Million |
| Acquisitions | 6652.08 | 886.12 Thousand | 8.19 Million | 2.73 Million | 676.75 Thousand | 134.13 Million |
| Investment purchases | -3.07 Billion | -2.88 Billion | -50.7 Million | -152.05 Million | -704.63 Thousand | -320.59 Thousand |
| Sales/Maturities of investments | 2.09 Billion | 1.14 Billion | 73.66 Million | 159.03 Million | 11.83 Million | 3.05 Million |
| Other Investing Activities | 20 Million | -850 Million | 2.53 Million | 85.31 Million | -48.17 Million | -243.33 Million |
| Financing Cash Flow | -893.25 Million | 3.12 Billion | 52.78 Million | 379.79 Million | -5.17 Million | -29.05 Million |
| Debt repayment | -38.03 Million | -346.35 Million | -77.59 Million | -33.76 Million | - | -197.34 Million |
| Dividends payments | -904.48 Million | -121.4 Million | -108.4 Million | -1.65 Million | -1.04 Million | -6.29 Million |
| Common Stock Repurchased | -15.65 Million | -200.16 Million | - | - | - | - |
| Common Stock Issuance | -22.16 Million | 200.16 Million | - | - | - | - |
| Other Financing Activities | -11.15 Million | 3.6 Billion | 243.12 Million | 415.21 Million | -4.13 Million | 174.58 Million |
| Accounts receivables | 984.81 Million | -1.77 Billion | -1.7 Billion | -487.31 Million | -81.74 Million | - |
| Accounts payables | -935.61 Million | 1.11 Billion | 1.32 Billion | 287.39 Million | 137.3 Million | - |
| Inventory | -218.34 Million | -296.47 Million | -222.97 Million | -190.67 Million | -49.64 Million | -62.3 Million |
| Other working capital | -1.04 Billion | 20.11 Million | -12.47 Million | 38.31 Million | -29.65 Million | 20.15 Million |
| Cash at beginning of period | 5.19 Billion | 1.41 Billion | 701.46 Million | 157.87 Million | 88.52 Million | 260.82 Million |
| Cash at end of period | 3.81 Billion | 5.18 Billion | 1.41 Billion | 701.46 Million | 157.87 Million | 88.52 Million |
| Capital Expenditure | -1.15 Billion | -929.91 Million | -1.04 Billion | -390.43 Million | -162 Million | -246.06 Million |
| Effect of forex changes on cash | 7.61 Million | 26.26 Million | -8.74 Million | -9 Million | 217.02 Thousand | 962.02 Thousand |
| Net cash flow / Change in cash | -1.37 Billion | 3.77 Billion | 711.88 Million | 543.59 Million | 69.35 Million | -172.3 Million |
| Free Cash Flow | 444.37 Million | 3.2 Billion | 634.15 Million | 77.76 Million | 110.67 Million | -37.75 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.16 Million | 134.77 Million | 125.7 Million | -560.68 Million | 1.24 Billion | 106 Million |
| Depreciation & Amortization | - | 70.59 Million | 70.59 Million | 77.97 Million | 255.61 Million | -102.54 Million |
| Deferred income taxes | - | - | - | - | -109.1 Million | -936.84 Million |
| Stock-based compensation | - | - | - | - | - | -5.67 Million |
| Change in working capital | - | 430.88 Million | - | 766.46 Million | -169.14 Million | 991.64 Million |
| Other non-cash items | 85.14 Million | 66.74 Million | -74.13 Million | 360.06 Million | 1.05 Billion | 672.36 Million |
| Investing Cash Flow | -401.58 Million | -398.09 Million | -96.25 Million | -543.33 Million | -2.11 Billion | -736.46 Million |
| Investments in PPE | -248.33 Million | -279.67 Million | -176.89 Million | -292.5 Million | -1.15 Billion | -259.17 Million |
| Acquisitions | 14.68 Million | 1.28 Million | 10.7 Thousand | -117.02 Thousand | 6652.08 | 4452.35 |
| Investment purchases | 2.99 Billion | -2.99 Billion | - | -3.06 Billion | -3.07 Billion | 1.44 Billion |
| Sales/Maturities of investments | 922.06 Million | 328.39 Million | 2.63 Billion | -434.99 Million | 2.09 Billion | 1.31 Billion |
| Other Investing Activities | -1.07 Billion | 2.55 Billion | -2.55 Billion | 3.25 Billion | 20 Million | -3.23 Billion |
| Financing Cash Flow | -130.29 Million | -483.59 Million | -5.76 Million | 32.5 Million | -893.25 Million | -34.76 Million |
| Debt repayment | -10.84 Million | -76.87 Million | -6.74 Million | -36.27 Million | -38.03 Million | -74.39 Million |
| Dividends payments | -925.55 Thousand | -406.32 Million | -1.18 Million | -904.48 Million | -904.48 Million | -18.56 Million |
| Common Stock Repurchased | 50.73 Million | -50.73 Million | - | -15.65 Million | -15.65 Million | - |
| Common Stock Issuance | - | - | - | -22.16 Million | -22.16 Million | - |
| Other Financing Activities | -140.21 Million | -353.67 Million | -12.5 Million | 916.37 Million | -11.15 Million | 58.2 Million |
| Accounts receivables | - | 373.06 Million | - | 984.81 Million | 984.81 Million | 760.59 Million |
| Accounts payables | - | - | - | - | -935.61 Million | - |
| Inventory | - | 57.82 Million | - | -218.34 Million | -218.34 Million | 231.05 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 2.98 Billion | 3.76 Billion | 3.81 Billion | 3.66 Billion | 5.19 Billion | 3.7 Billion |
| Cash at end of period | 2.51 Billion | 3 Billion | 3.76 Billion | 3.81 Billion | 3.81 Billion | 3.65 Billion |
| Capital Expenditure | -248.33 Million | -279.67 Million | -176.89 Million | -292.5 Million | -1.15 Billion | -259.17 Million |
| Effect of forex changes on cash | -4.86 Million | 1.18 Million | 204.61 Thousand | -2.02 Million | 7.61 Million | -1.55 Million |
| Net cash flow / Change in cash | -467.48 Million | -767.71 Million | -50.28 Million | 150.04 Million | -1.37 Billion | -47.83 Million |
| Free Cash Flow | -157.02 Million | -148.74 Million | -125.32 Million | 351.31 Million | 444.37 Million | 465.77 Million |
PNE3
TRIS
TPE
ETLN
CMBN
IJ8